Dr. Pedro T. Ramirez is Chair in the Department of Obstetrics and Gynecology at Houston Methodist Hospital. He completed his residency training at Columbia Presbyterian Medical Center in New York City. He then came to MD Anderson Cancer Center to complete a Fellowship in Gynecologic Oncology. After completion he remained on faculty there for 25 years. He was also the recipient of the David M. Gershenson Distinguished Professor in Ovarian Cancer Research Endowment and of the Randall Prize for Excellence in Cancer Treatment. 
Dr. Ramirez is also the Editor-in-Chief of the International Journal of Gynecological Cancer. He has published a total of 306 manuscripts in peer-reviewed journals, including the New England Journal of Medicine and has published a total of 19 book chapters. In addition, he is the Editor for the textbook titled Principles of Gynecologic Oncology Surgery. He is also Co-Editor of a textbook published in 2022 titled The ERAS Society Handbook for Obstetrics & Gynecology. 

Dr. Ramirez was the Principal Investigator in the LACC Trial: A Phase III Randomized Clinical Trial of Laparoscopic or Robotic Radical Hysterectomy versus Abdominal Radical Hysterectomy in Patients with Early Stage Cervical Cancer. This landmark study showed that minimally invasive radical hysterectomy in patients with early-stage cervical cancer was associated with a worse disease-free survival, recurrence rate, progression-free survival, and overall survival when compared to the open approach. These results have been practice changing and all guidelines have changed to the open approach as the standard of care when performing radical hysterectomy. The study was published in The New England Journal of Medicine. Most recently, Dr. Ramirez was made member of the IDEAL Council at Oxford University in England. In this role, he collaborates with leaders in the field of surgical research on developing strategies to integrate innovative surgical tools to the standard of care practice in patients with gynecological cancers.